DHX9 and cancer: The expression of DHX9 was significantly associated with the abundance of infiltrating immune cells: B cells in 17 cancers, CD8+ T cells in 22 cancers, CD4+ T cells in 12 cancers, neutrophils in 31 cancers, macrophages and myeloid dendritic cells in 18 cancers (Figure 5A).